Nature Reviews Cancer, Published online: 19 February 2024; doi:10.1038/s41568-023-00662-7In this Viewpoint article, we asked five Black cancer researchers and clinicians to present their ideas on how we can attract and retain more diverse researchers to the cancer community and how we begin to close the gap in cancer disparities.
Nature Reviews Cancer, Published online: 12 February 2024; doi:10.1038/s41568-023-00660-9In their Review article, Fuchs and colleagues discuss how a single or a few mutations in adult cells can lead to invasive cancers without a high mutational burden, demonstrating that non-genetic factors induce the epigenetic changes necessary for tumorigenesis.
Nature Reviews Cancer, Published online: 12 February 2024; doi:10.1038/s41568-024-00665-yIn this Viewpoint article, we asked three scientists working on the cancer mycobiome to provide their opinions on advancements and challenges and what the future holds for this exciting field of cancer research.
Nature Reviews Cancer, Published online: 09 February 2024; doi:10.1038/s41568-024-00671-0In this Tools of the Trade, Juliann Shih describes the development of BISCUT, which detects genomic loci that are subject to fitness advantages or disadvantages by interrogating the length distributions of partial somatic copy-number alterations to enable the discovery...
Nature Reviews Cancer, Published online: 08 February 2024; doi:10.1038/s41568-023-00659-2In this Viewpoint, we asked four experts to discuss the increasing burden of cancer in low- and middle-income countries; they explore the changes that are necessary to improve cancer diagnosis, prevention and treatment within these nations.
Nature Reviews Cancer, Published online: 06 February 2024; doi:10.1038/s41568-024-00675-wMutant gain-of-function p53 is commonly found in human cancers. Huang, Cao, Qian et al. developed and validated the use of multifunctional biomimetic nanoreceptors that bind to and promote the degradation of mutant p53 as a cancer therapy.